News
SBFM
1.360
-1.45%
-0.020
Weekly Report: what happened at SBFM last week (0331-0404)?
Weekly Report · 6d ago
Sunshine Biopharma Secures $2.46 Million in Direct Offering
TipRanks · 04/03 20:37
Sunshine Biopharma Closes $2.46 Million Direct Offering
TipRanks · 04/03 20:37
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 04/03 12:05
3 Penny Stocks to Watch Now, 4/3/25
TipRanks · 04/03 08:32
Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022
TipRanks · 04/02 21:41
Sunshine Biopharma Announces $2.46M Registered Direct Offering At $2.07 A Share
Benzinga · 04/02 17:24
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 04/02 17:06
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug
Benzinga · 04/02 15:35
Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product
TipRanks · 04/02 12:15
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 04/02 12:05
US Stock Futures Slip Ahead Of 'Liberation Day' Tariffs Announcement: Expert Points To Uncertainty Amid Higher Risk Premia
Benzinga · 04/02 09:54
Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/02 08:57
Sunshine Biopharma reports FY results
Seeking Alpha · 04/02 04:55
Closing Bell Movers: nCino down 29% on earnings miss
TipRanks · 04/01 23:35
Sunshine Biopharma reports FY24 revenue $34.9M vs $24.1M last year
TipRanks · 04/01 21:15
Sunshine Biopharma Delays Financial Report Filing
TipRanks · 03/31 22:43
Weekly Report: what happened at SBFM last week (0324-0328)?
Weekly Report · 03/31 11:25
Sunshine Biopharma Inc <SBFM.OQ> expected to post earnings of 11 cents a share - Earnings Preview
Reuters · 03/28 20:07
Sunshine Biopharma Inc <SBFM.OQ> expected to post earnings of 11 cents a share - Earnings Preview
Reuters · 03/24 20:06
More
Webull provides a variety of real-time SBFM stock news. You can receive the latest news about Sunshine Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SBFM
More
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.